1 year return (CAGR)
-21.31%
ARS Pharmaceuticals, Inc Exchange (NASDAQ, USD)
SPRY
4.76
+0.53 (+5.99%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
5.89%
5 year return (CAGR)
-26.28%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
931.44M
Price/Sales
11.05
Ent value
1.10B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 8.66 |
| Daily high | 9.52 |
| Daily low | 8.66 |
| Daily Volume | 886K |
| All-time high | 60.41 |
| 1y analyst estimate | 23.25 |
| Beta | 1.00 |
| EPS (TTM) | -2.17 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Mar 2026 |
Downside potential
Loading...
Downside potential data
| SPRY | S&P500 | |
| Current price drop from All-time high | -92.12% | -1.75% |
| Highest price drop | -95.20% | -56.47% |
| Date of highest drop | 11 May 2022 | 9 Mar 2009 |
| Avg drop from high | -77.75% | -10.68% |
| Avg time to new high | 59 days | 12 days |
| Max time to new high | 1236 days | 1805 days |
News
